UNCOVERED: 9 - The Untold Story

Baby formula disaster failed to dent Abbott Labs’ ESG score

Several months after the US government began investigating an Abbott Laboratories baby-formula plant for its connection to the deaths of at least two infants, the world’s most influential judge of corporate environmental, social and governance practices upgraded the company.

Tribune News Service · Oct 13, 2022

Sheryl Lee Ralph on Abbott Elementary, being ‘black famous’ and scolding Kimmel

The 65-year-old mega-talent has been criminally underappreciated until now – ‘Isn’t it such a blessing that I could remain relevant after all of these years?’

The Guardian - US · Oct 4, 2022

Here's what the FDA says contributed to the baby formula shortage crisis

The Food and Drug Administration rattled off 15 reasons behind the national baby formula shortage, but couldn't identify a specific person or agency responsible.

WEKU · Sep 23, 2022

Latest recalls of formula meant frantic search for family of suburban boy, 5, who needs it to survive

With help from La Rabida Children’s Hospital, Zayne Negoski of Joliet got an alternative tube-feeding formula. But his family and those of other medically needy kids have struggled and often had to pay more after Aug. 10 recall.

Chicago Sun-Times · Aug 26, 2022

More from 'Abbott Elementary' creator Quinta Brunson on the way, thanks to new overall deal with Warner Bros.

PHILADELPHIA — The world is about to see a whole lot more from Abbott Elementary star and creator Quinta Brunson.

The Philadelphia Inquirer · Aug 15, 2022

Is Abbott Labs A "Strong Buy" After Earnings?

Leading healthcare company Abbott Laboratories (ABT) reported strong second-quarter results. And given the company is well-positioned to capitalize on its diverse business and recent FDA approvals, is it wise to buy the stock now? Let’s find out.

StockNews.com · Jul 27, 2022

Abbott reports strong earnings despite infant formula crisis

Abbott Laboratories reported strong earnings Wednesday, despite spending recent months responding to criticism over problems that led to the shutdown of one of its infant formula-producing plants.

Chicago Tribune · Jul 20, 2022

2 Medical Stocks That Are Attractive Buys Right Now

Amid an inflationary environment, the medical sector is poised to stay afloat given the inelastic demand for medical products and services, impressive breakthroughs, and the rising need to serve an aging population. Therefore, fundamentally sound medical stocks Abbott Laboratories (ABT) and Utah Medical Products (UTMD) could be solid investments right…

StockNews.com · Jul 18, 2022

Is Abbott Stock a Buy at $105 as Production in Troubled Plant Resumes?

Leading healthcare company Abbott Laboratories (ABT) reported robust first-quarter results. And the company is well-positioned to benefit from its diversified business. Moreover, as ABT is resuming infant formula production at its Michigan facility, is the stock a good buy at the current price level? Read more to find out….

StockNews.com · Jul 15, 2022

Quinta Brunson had the perfect response to Jimmy Kimmel's dumb Emmys bit

"I'm going to be on his show on Wednesday, so I might punch him in the face. I don't know, we’ll see what happens.”

Mic · Jul 12, 2022